The question for biomanufacturing leaders is no longer whether to modernize their scientific data infrastructure, but how ...

A recent research finding adds to evidence that brain inflammation is a major driver of neurodegenerative disorders such as ...

Illumina has entered into a definitive agreement with Standard BioTools under which the company will acquire SomaLogic.

A new potential drug treatment for people with type 2 diabetes and obesity lowers blood sugar and increases fat burning.

LOTTE will manufacture antibody drug substance for Ottimo Pharma’s product at LOTTE’s Syracuse Bio Campus in New York.